Skip to main content

Intellectual Property

Viewpoints

Filter by:

Intellectual Property Viewpoints Thumbnail

How Can the Updated USPTO Guidance on Determining Obviousness Help You?

March 7, 2024 | Blog | By Peter Hecker, PhD, Jenny Chen, PhD, Ken Jenkins, Christina Sperry

Read more
Intellectual Property Viewpoints Thumbnail

Another Implementer Hold Out Door Closes: The Death of the Anti-Suit Injunction?

February 28, 2024 | Blog | By Daniel Weinger, Andrew DeVoogd, Courtney Herndon, Laura Petrasky

Read more
Intellectual Property Viewpoints Thumbnail
The United States Patent and Trademark Office (USPTO) released the web-based Patent Public Search tool ("PPS") in late 2021. This useful tool is comparable to the search tool that the PTO’s own examiner’s use to find prior art. That said, PPS has a real learning curve in developing effective search queries. In this article we offer a starting point in developing search queries that will return relevant results.
Read more

How Your Trade Secret Could Help to Defend Against Claims of Patent Infringement

February 1, 2024 | Blog | By Adam Samansky, Peter Cuomo, Nicholas Armington, Stephen Chen

Read more
Intellectual Property Viewpoints Thumbnail

How Compulsory Licenses Can Affect Domestic and Foreign Prosecution

January 24, 2024 | Blog | By Michael Van Loy, Sophia Petrichenko

Read more
Intellectual Property Viewpoints Thumbnail

Year in Review: The Most Popular IP Posts of 2023

January 4, 2024 | Blog | By Christina Sperry

Read more
Intellectual Property Viewpoints Thumbnail

Basics – How an Inventor’s Own Work Affects Patent Applications

December 6, 2023 | Blog | By Peter Hecker, PhD, Lee Johnson, PhD

Read more
Intellectual Property Viewpoints Thumbnail

The Impact of Venture Capital Funding on Entity Status

November 10, 2023 | Blog | By Michael Van Loy, Jessica Zhang, Qi Zhang

Understanding the implications of venture capital funding on a company’s size classification is crucial, especially when it jeopardizes its “small entity” status and raises concerns with the United States Patent and Trademark Office. Member Michael D. Van Loy, PhD and Associates Jessica Zhang and Qi Zhang break down these complexities, underscoring the importance of accurately determining entity status to avoid pitfalls such as patent invalidation.
Read more
Intellectual Property Viewpoints Thumbnail

AI-Based Patent Applications: Recent History and the Future

October 30, 2023 | Blog | By Vishak Ganesh, Frank Gerratana

Read more
Intellectual Property Viewpoints Thumbnail

Federal Circuit Puts the Onus on Patent Owners to Disclaim Patent Term or Face Double-Patenting

September 7, 2023 | Blog | By Peter Cuomo, Thomas Wintner, James Whittle, PhD

Read more
Intellectual Property Viewpoints Thumbnail

Picture Claims as an Effective Patent Strategy: Top 10 Reasons to Precisely Tailor Your Patent Claim

September 6, 2023 | Blog | By James Whittle, PhD, Terri Shieh-Newton, Dean Farmer, PhD

Read more
Intellectual Property Viewpoints Thumbnail

Can Enablement and Written Description Bars be Lower for Method-Of-Treatment Patent Claims?

August 21, 2023 | Blog | By Lei Xu, PhD, Dean Farmer, PhD, Christina Sperry

Read more
Intellectual Property Viewpoints Thumbnail

Distinguishing Patent Protection from Patient Safety – A Role for the FDA

August 21, 2023 | Blog | By Peter Hecker, PhD, Lee Johnson, PhD

Read more
Intellectual Property Viewpoints Thumbnail

An Overview of Shotgun Pleadings in the Federal Courts

August 7, 2023 | Blog | By Joe Rutkowski, Peter Cuomo

Read more
Intellectual Property Viewpoints Thumbnail
Clinical trial related patent applications are often filed prior to the start of the Phase I clinical trial to minimize the risk of invalidation of the resulting patent for public use (35 U.S.C. § 102(a)) based on the clinical trial itself.  This conservative filing strategy is unnecessary for the majority of clinical trial-related inventions, and reduces the value of the patent by prematurely starting the patent term clock.
Read more

Explore Other Viewpoints: